UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Salivary Cortisone Is a Potential Biomarker for Serum Free Cortisol

The journal of clinical endocrinology and metabolism, 2010-11, Vol.95 (11), p.4951-4958

2010

Volltextzugriff (PDF)

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy

Endocrine Connections, 2018-07, Vol.7 (7), p.G1-G7

2018

Volltextzugriff (PDF)

Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice

Clinical endocrinology (Oxford), 2007-07, Vol.67 (1), p.65-70

2007

Volltextzugriff (PDF)

Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly

Endocrine reviews, 2002-10, Vol.23 (5), p.623-646

2002

Volltextzugriff (PDF)

Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.1187-1193

2012

Volltextzugriff (PDF)

Pegvisomant Improves Insulin Sensitivity and Reduces Overnight Free Fatty Acid Concentrations in Patients with Acromegaly

The journal of clinical endocrinology and metabolism, 2009-07, Vol.94 (7), p.2459-2463

2009

Volltextzugriff (PDF)

Changes in Arterial Stiffness But Not Carotid Intimal Thickness in Acromegaly

The journal of clinical endocrinology and metabolism, 2011-05, Vol.96 (5), p.1486-1492

2011

Volltextzugriff (PDF)

Long-term experience of pegvisomant therapy as a treatment for acromegaly

Clinical endocrinology (Oxford), 2009-07, Vol.71 (1), p.86-91

2009

Volltextzugriff (PDF)

Corticosteroid-binding globulin regulates cortisol pharmacokinetics

Clinical endocrinology (Oxford), 2011-01, Vol.74 (1), p.30-36

2011

Volltextzugriff (PDF)

Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study

Clinical endocrinology (Oxford), 2016-10, Vol.85 (4), p.569-574

2016

Volltextzugriff (PDF)

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide

Clinical endocrinology (Oxford), 2008-06, Vol.68 (6), p.970-975

2008

Volltextzugriff (PDF)

Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours

Clinical endocrinology (Oxford), 2016-03, Vol.84 (3), p.348-352

2016

Volltextzugriff (PDF)

Novel Corticosteroid-Binding Globulin Variant That Lacks Steroid Binding Activity

The journal of clinical endocrinology and metabolism, 2010-10, Vol.95 (10), p.E142-E150

2010

Volltextzugriff (PDF)

Serum regulates cortisol bioactivity by corticosteroid-binding globulin-dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches

Clinical endocrinology (Oxford), 2011-07, Vol.75 (1), p.31-38

2011

Volltextzugriff (PDF)

Pegvisomant-Induced Serum Insulin-Like Growth Factor-I Normalization in Patients with Acromegaly Returns Elevated Markers of Bone Turnover to Normal

The journal of clinical endocrinology and metabolism, 2003-12, Vol.88 (12), p.5650-5655

2003

Volltextzugriff (PDF)

Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant

European journal of endocrinology, 2003-12, Vol.149 (6), p.521-527

2003

Volltextzugriff (PDF)

Successful use of weekly pegvisomant administration in patients with acromegaly

European journal of endocrinology, 2009-07, Vol.161 (1), p.21-25

2009

Volltextzugriff (PDF)

Pegvisomant interference in GH assays results in underestimation of GH levels

European journal of endocrinology, 2007-03, Vol.156 (3), p.315-319

2007

Volltextzugriff (PDF)

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome

The journal of clinical endocrinology and metabolism, 1999-02, Vol.84 (2), p.487-492

1999

Volltextzugriff (PDF)

Withdrawal of somatostatin analogue therapy in patients with acromegaly is associated with an increased risk of acute biliary problems

Clinical endocrinology (Oxford), 2007-05, Vol.66 (5), p.723-726

2007

Volltextzugriff (PDF)

A Comparison of the Effects of Pegvisomant and Octreotide on Glucose, Insulin, Gastrin, Cholecystokinin, and Pancreatic Polypeptide Responses to Oral Glucose and a Standard Mixed Meal

The journal of clinical endocrinology and metabolism, 2002-04, Vol.87 (4), p.1797-1804

2002

Volltextzugriff (PDF)

Growth hormone excess and the development of growth hormone receptor antagonists

Experimental physiology, 2008-11, Vol.93 (11), p.1157-1169

2008

Volltextzugriff (PDF)

Acute management of the endocrine complications of checkpoint inhibitor therapy

Endocrine Connections, 2018-07, Vol.7 (7), p.G1-G7

2018

Volltextzugriff (PDF)

Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults

The journal of clinical endocrinology and metabolism, 1998-11, Vol.83 (11), p.3913-3919

1998

Volltextzugriff (PDF)

A Subnormal Peak Cortisol Response to Stimulation Testing Does Not Predict a Subnormal Cortisol Production Rate

The journal of clinical endocrinology and metabolism, 2009-05, Vol.94 (5), p.1757-1760

2009

Volltextzugriff (PDF)

1 – 25 von 447

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(394)
Mit Volltextzugriff
(344)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(279)
Life Sciences & Biomedicine
(200)
Humans
(164)
Endocrinology & Metabolism
(119)
Biological And Medical Sciences
(112)
Male
(109)
Female
(104)
Medical Sciences
(99)
Adult
(95)
Physical Sciences
(93)
Middle Aged
(82)
Meteorology & Atmospheric Sciences
(71)
Exact Sciences And Technology
(66)
Endocrinopathies
(57)
Aged
(56)
Earth, Ocean, Space
(51)
Fundamental And Applied Biological Sciences. Psychology
(46)
Non Tumoral Diseases. Target Tissue Resistance. Benign Neoplasms
(42)
Acromegaly - Drug Therapy
(36)
Human Growth Hormone - Analogs & Derivatives
(36)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Salivary Cortisone Is a Potential Biomarker for Serum Free Cortisol

SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Acute management of the endocrine complications of checkpoint inhibitor therapy

Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice

Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly

Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial

Pegvisomant Improves Insulin Sensitivity and Reduces Overnight Free Fatty Acid Concentrations in Patients with Acromegaly

Changes in Arterial Stiffness But Not Carotid Intimal Thickness in Acromegaly

Long-term experience of pegvisomant therapy as a treatment for acromegaly

Corticosteroid-binding globulin regulates cortisol pharmacokinetics

Proopiomelanocortin interference in the measurement of adrenocorticotrophic hormone: a United Kingdom National External Quality Assessment Service study

Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide

Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours

Novel Corticosteroid-Binding Globulin Variant That Lacks Steroid Binding Activity

Serum regulates cortisol bioactivity by corticosteroid-binding globulin-dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches

Pegvisomant-Induced Serum Insulin-Like Growth Factor-I Normalization in Patients with Acromegaly Returns Elevated Markers of Bone Turnover to Normal

Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant

Successful use of weekly pegvisomant administration in patients with acromegaly

Pegvisomant interference in GH assays results in underestimation of GH levels

A critical analysis of the value of simultaneous inferior petrosal sinus sampling in Cushing's disease and the occult ectopic adrenocorticotropin syndrome

Withdrawal of somatostatin analogue therapy in patients with acromegaly is associated with an increased risk of acute biliary problems

A Comparison of the Effects of Pegvisomant and Octreotide on Glucose, Insulin, Gastrin, Cholecystokinin, and Pancreatic Polypeptide Responses to Oral Glucose and a Standard Mixed Meal

Growth hormone excess and the development of growth hormone receptor antagonists

Acute management of the endocrine complications of checkpoint inhibitor therapy

Optimizing Growth Hormone Replacement Therapy by Dose Titration in Hypopituitary Adults

A Subnormal Peak Cortisol Response to Stimulation Testing Does Not Predict a Subnormal Cortisol Production Rate

Suchergebnisse filtern